查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2149580

代謝健康與持續血糖監測市場預測至2034年－按產品類型、部署模式、連接與整合、分銷管道、應用、最終用戶和地區分類的全球分析

Metabolic Health & Continuous Glucose Monitoring Market Forecasts to 2034 - Global Analysis By Product Type (Devices, Sensors and Software & Apps), Deployment Mode, Connectivity & Integration, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球代謝健康和連續血糖監測市場規模將達到 100 億美元，並在預測期內以 12.8% 的複合年成長率成長，到 2034 年將達到 263 億美元。

代謝健康和持續血糖監測涵蓋旨在監測血糖值、分析代謝趨勢並鼓勵更健康生活方式選擇的解決方案。穿戴式持續血糖監測設備能夠實現持續血糖值測量，幫助使用者和醫療專業人員更有效地了解血糖變化和趨勢。該市場包括監測技術、互聯數位平台、數據分析和個人化健康計劃。人們對預防醫學、代謝健康維護、個人化營養管理和數位化健康管理的日益關注，不僅推動了糖尿病患者的採用，也促進了關注代謝健康預防的消費者對這些技術的應用。

根據世界衛生組織的數據，18 歲及以上成年人的糖尿病盛行率已從 1990 年的 6.8% 上升到 2022 年的 14.1%，這凸顯了對能夠進行血糖值監測和糖尿病管理的技術的需求。

糖尿病和代謝性疾病盛行率增加

糖尿病和代謝性疾病的日益普及推動了對持續血糖監測 (CGM) 解決方案的需求。 CGM 技術提供持續的血糖值監測，幫助使用者識別血糖變化並據此調整飲食、運動或治療方案。其角色也正從傳統的糖尿病管理擴展到更廣泛的預防性醫療保健領域。醫療專業人員可以利用持續血糖資訊來制定更個人化的照護方案，而消費者也擴大將血糖監測用於營養管理、運動、體重管理和整體健康改善。這種更廣泛的需求為代謝健康監測技術創造了更多機會。

連續血糖監測設備高成本

持續血糖監測（CGM）系統的高昂成本可能會限制代謝健康和持續血糖監測市場的成長。這些成本可能包括穿戴式感測器、發送器、訂閱服務和數位服務，以及持續的感測器更換費用。保險覆蓋不足或有限可能會進一步加重用戶的自付費用負擔。因此，對價格敏感的消費者可能會對採用持續監測技術猶豫不決，尤其是在傳統血糖檢測提供更低成本替代方案的情況下。這些經濟挑戰可能會減緩服務不足人口的接受度，並限制醫療費用支出相對較低的市場的滲透率。

將 CGM 的應用範圍擴展到糖尿病管理之外

動態血糖監測（CGM）技術在傳統糖尿病照護之外的更廣泛應用，為市場拓展帶來了機會。持續血糖數據有助於使用者了解自身血糖值波動模式及其與飲食、運動、睡眠和日常活動的關聯。人們對預防醫學和個人化健康管理的日益關注，並有望推動未確診糖尿病族群對該技術的接受度。與營養服務機構、健身應用程式、體重管理專案和數位健康平台建立合作關係，可拓展CGM解決方案的應用範圍。此類整合將進一步刺激市場需求，並協助製造商和醫療技術公司開發新的代謝健康相關服務。

網路安全風險和未授權存取健康數據

由於連網的持續血糖監測（CGM）系統處理高度敏感的健康訊息，網路安全挑戰可能會阻礙「代謝健康和持續血糖監測市場」的成長。設備、應用程式或雲端平台中的安全漏洞、未授權存取或資料外洩都可能危及用戶數據，並削弱用戶對數位監控解決方案的信任。隨著CGM設備、智慧型手機、醫療保健平台和雲端基礎設施之間互聯互通程度的加深，網路安全威脅的風險也隨之增加。因此，製造商和服務供應商可能面臨越來越大的安全投資、隱私保護、合規性和持續系統保護的要求，以維護消費者的信任。

新型冠狀病毒（COVID-19）的影響：

新冠疫情凸顯了代謝健康和遠距血糖監測的重要性，尤其是在醫療服務中斷和麵對面就診減少的情況下。持續血糖監測（CGM）系統使患者和臨床醫生能夠遠端獲取血糖值訊息，從而變得日益重要。然而，封鎖措施、供應鏈中斷、生產困難以及醫療服務取得受限，都為某些市場的產品供應和普及帶來了挑戰。同時，疫情也加速了遠端醫療和數位健康的發展，為將持續血糖監測整合到遠距患者照護、糖尿病管理和個人化代謝健康服務中奠定了堅實的基礎。

在預測期內，感測器產業預計將佔據最大的市場佔有率。

預計在預測期內，感測器領域將佔據最大的市場佔有率，因為它是實現連續血糖監測的基礎技術。感測器使連續血糖監測系統能夠讀取組織液中的血糖值，並將訊息傳輸至連接的設備和軟體平台。對連續、即時血糖監測日益成長的需求，推動了先進感測器技術的重要性。感測器精度的提高、緊湊的設計、舒適性、佩戴性和使用壽命的延長，也增強了感測器在糖尿病管理中連續血糖監測解決方案的作用，並拓展了其在代謝健康監測方面的應用範圍。

在預測期內，健身和健康中心細分市場預計將呈現最高的複合年成長率。

在預測期內，健身和健康中心領域預計將呈現最高的成長率，因為消費者越來越關注預防醫學、個人化健身和代謝健康管理。這些機構可以利用持續血糖監測（CGM）技術來支持個人化的營養管理、運動、體重管理和生活方式規劃。消費者對了解血糖值如何隨飲食和運動變化的興趣日益濃厚，這為CGM的更廣泛應用創造了機會。透過將血糖值資訊與健身應用程式和健康平台整合，可以提供個人化的見解，從而鼓勵更健康的行為，並加速在整個以健康為導向的環境中推廣持續代謝監測解決方案。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其完善的醫療保健系統、數位健康技術的廣泛應用以及持續血糖監測（CGM）解決方案使用量的不斷成長。全部區域需求。美國是主要貢獻者，這得益於其龐大的糖尿病患者群體、完善的醫療保健基礎設施、保險覆蓋範圍以及在CGM行業的強大影響力。血糖值監測儀、智慧型手機、遠距醫療平台和個人化健康服務之間日益緊密的整合也推動了該地區市場的持續發展。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於糖尿病患病率的上升、醫療保健系統的改善以及數位健康解決方案的日益普及。人們對血糖控制和預防醫學的日益重視，推動了對持續血糖監測的興趣。該地區的醫療保健系統正日益將數位技術融入糖尿病管理和基層醫療中。對互聯醫療設備、遠端醫療和個人化治療方案的持續投入，預計將全部區域的持續血糖監測技術和代謝健康監測創造更多機會。

免費客製化服務：

所有購買此報告的客戶均可選擇以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶的興趣，我們將提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球代謝健康與持續血糖監測市場：依產品類型分類

  • 裝置
  • 感應器
  • 軟體和應用程式

第6章 全球代謝健康與持續血糖監測市場：依部署模式分類

  • 穿戴式系統
  • 嵌入式系統

第7章 全球代謝健康和持續血糖監測市場：按連接性和整合性分類

  • 相容智慧型手機
  • 基於雲端的平台
  • 獨立設備

第8章：全球代謝健康與持續血糖監測市場：按分銷管道分類

  • 零售藥房
  • 醫院藥房
  • 線上平台

第9章 全球代謝健康與持續血糖監測市場：按應用分類

  • 糖尿病管理
  • 肥胖和體重管理
  • 預防性代謝監測
  • 運動和表現的最佳化

第10章 全球代謝健康與持續血糖監測市場：依最終使用者分類

  • 醫院和診所
  • 居家照護環境
  • 健身健康中心

第11章 全球代謝健康與持續血糖監測市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Abbott Laboratories
  • Dexcom
  • Medtronic
  • Senseonics Holdings
  • Roche Diagnostics
  • Ascensia Diabetes Care
  • Medtrum Technologies
  • i-SENS
  • Nemaura Medical
  • Bionime Corporation
  • Zhejiang POCTech
  • Biolinq
  • Ultrahuman
  • GlySens
  • Levels Health
  • Nutrisense
  • January AI
  • Signos
Product Code: SMRC40067

According to Stratistics MRC, the Global Metabolic Health & Continuous Glucose Monitoring Market is accounted for $10.0 billion in 2026 and is expected to reach $26.3 billion by 2034 growing at a CAGR of 12.8% during the forecast period. Metabolic Health & Continuous Glucose Monitoring covers solutions designed to monitor glucose levels, interpret metabolic trends, and encourage healthier lifestyle choices. Wearable continuous glucose monitoring devices deliver ongoing glucose measurements, allowing users and clinicians to recognize changes and patterns more effectively. The market includes monitoring technologies, connected digital platforms, data analytics, and personalized health programs. Increasing interest in preventive care, metabolic wellness, personalized nutrition, and digitally supported health management is driving broader use among individuals managing diabetes as well as consumers focused on proactive metabolic health.

According to WHO, diabetes prevalence among adults aged 18 years and older increased from 6.8% in 1990 to 14.1% in 2022, supporting demand for technologies that enable glucose monitoring and diabetes management.

Market Dynamics:

Driver:

Rising prevalence of diabetes and metabolic disorders

Growing rates of diabetes and metabolic health conditions are supporting demand for continuous glucose monitoring solutions. CGM technologies provide ongoing glucose measurements that help users recognize changes and make informed adjustments to diet, activity, or treatment. Their role is also expanding from conventional diabetes management toward broader preventive healthcare. Healthcare professionals can use continuous glucose information to develop more personalized care approaches, while consumers increasingly explore glucose monitoring for nutrition, exercise, weight management, and general wellness. This wider interest is creating additional opportunities for metabolic health monitoring technologies.

Restraint:

High cost of continuous glucose monitoring devices

High expenses associated with CGM systems can constrain the expansion of the Metabolic Health & Continuous Glucose Monitoring Market. Costs may include wearable sensors, transmitters, subscriptions, and digital services, while sensor replacement creates recurring financial commitments. Inadequate reimbursement or limited healthcare coverage can further increase the burden for users paying independently. Consequently, price-conscious consumers may hesitate to adopt continuous monitoring technologies, especially when traditional glucose testing provides a lower-cost alternative. These affordability challenges can slow adoption among underserved populations and limit penetration in markets where healthcare spending remains comparatively constrained.

Opportunity:

Expansion of CGM applications beyond diabetes management

The broader use of CGM technologies beyond conventional diabetes care presents opportunities for market expansion. Continuous glucose data can help users understand relationships between glucose patterns, food intake, exercise, sleep, and everyday behaviors. Increasing interest in preventive healthcare and personalized wellness could support adoption among consumers without diagnosed diabetes. Partnerships with nutrition services, fitness applications, weight-management programs, and digital wellness platforms may expand the role of CGM solutions. Such integration can create additional demand and enable manufacturers and healthcare technology companies to develop new metabolic health offerings.

Threat:

Cybersecurity risks and unauthorized health data access

Cybersecurity concerns may challenge the growth of the Metabolic Health & Continuous Glucose Monitoring Market because connected CGM systems handle sensitive health information. Security weaknesses, unauthorized access, or breaches involving devices, applications, or cloud platforms could compromise user data and affect confidence in digital monitoring solutions. Greater integration among CGM devices, smartphones, healthcare platforms, and cloud infrastructure can increase exposure to cybersecurity threats. Manufacturers and service providers may consequently face rising requirements for security investments, privacy safeguards, regulatory compliance, and ongoing system protection to preserve consumer trust.

Covid-19 Impact:

COVID-19 highlighted the importance of metabolic health and remote glucose monitoring as healthcare services experienced interruptions and fewer face-to-face consultations. CGM systems became increasingly useful by enabling patients and clinicians to access glucose information remotely. However, lockdown measures, disrupted supply chains, manufacturing difficulties, and limited healthcare access created challenges for product availability and adoption across certain markets. The pandemic simultaneously accelerated telemedicine and digital health usage, creating stronger foundations for incorporating continuous glucose monitoring into remote patient care, diabetes management, and personalized metabolic health services.

The sensors segment is expected to be the largest during the forecast period

The sensors segment is expected to account for the largest market share during the forecast period because they serve as the fundamental technology enabling continuous glucose measurement. They allow CGM systems to obtain glucose readings from interstitial fluid and support the transfer of information to connected devices and software platforms. Growing preference for continuous and real-time glucose monitoring has increased the importance of advanced sensor technologies. Improvements in sensor precision, compact design, comfort, wearability, and usage duration are also strengthening their role in CGM solutions used for diabetes management and expanding metabolic health monitoring applications.

The fitness & wellness centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the fitness & wellness centers segment is predicted to witness the highest growth rate as consumers increasingly focus on preventive healthcare, personalized fitness, and metabolic wellness. These settings can use CGM technologies to support individualized nutrition, exercise, weight-management, and lifestyle programs. Greater consumer interest in understanding glucose responses to meals and physical activity is creating opportunities for broader CGM use. Connecting glucose information with fitness applications and wellness platforms can provide personalized insights, encourage healthier behaviors, and strengthen the adoption of continuous metabolic monitoring solutions across wellness-oriented environments.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by established healthcare systems, broad adoption of digital health technologies, and increasing utilization of CGM solutions. Strong awareness of diabetes management supports demand across the region. The United States is a key contributor, supported by its substantial diabetes population, developed healthcare infrastructure, insurance coverage, and strong CGM industry presence. Greater connectivity between glucose monitors, smartphones, remote-care platforms, and personalized health services is also supporting continued development of the regional market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rising diabetes prevalence, improving healthcare systems, and greater use of digital health solutions. Growing awareness of glucose control and preventive wellness is supporting interest in continuous monitoring. Regional healthcare systems are increasingly integrating digital technologies into diabetes management and primary care. Expanding investment in connected medical devices, remote healthcare, and personalized treatment approaches is expected to create additional opportunities for CGM technologies and metabolic health monitoring across the region.

Key players in the market

Some of the key players in Metabolic Health & Continuous Glucose Monitoring Market include Abbott Laboratories, Dexcom, Medtronic, Senseonics Holdings, Roche Diagnostics, Ascensia Diabetes Care, Medtrum Technologies, i-SENS, Nemaura Medical, Bionime Corporation, Zhejiang POCTech, Biolinq, Ultrahuman, GlySens, Levels Health, Nutrisense, January AI and Signos.

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion.

Product Types Covered:

  • Devices
  • Sensors
  • Software & Apps

Deployment Modes Covered:

  • Wearable Systems
  • Implantable Systems

Connectivity & Integrations Covered:

  • Smartphone-Integrated
  • Cloud-Based Platforms
  • Standalone Devices

Distribution Channels Covered:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Platforms

Applications Covered:

  • Diabetes Management
  • Obesity & Weight Management
  • Preventive Metabolic Monitoring
  • Sports & Performance Optimization

End Users Covered:

  • Hospitals & Clinics
  • Homecare Settings
  • Fitness & Wellness Centers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Metabolic Health & Continuous Glucose Monitoring Market, By Product Type

  • 5.1 Devices
  • 5.2 Sensors
  • 5.3 Software & Apps

6 Global Metabolic Health & Continuous Glucose Monitoring Market, By Deployment Mode

  • 6.1 Wearable Systems
  • 6.2 Implantable Systems

7 Global Metabolic Health & Continuous Glucose Monitoring Market, By Connectivity & Integration

  • 7.1 Smartphone-Integrated
  • 7.2 Cloud-Based Platforms
  • 7.3 Standalone Devices

8 Global Metabolic Health & Continuous Glucose Monitoring Market, By Distribution Channel

  • 8.1 Retail Pharmacies
  • 8.2 Hospital Pharmacies
  • 8.3 Online Platforms

9 Global Metabolic Health & Continuous Glucose Monitoring Market, By Application

  • 9.1 Diabetes Management
  • 9.2 Obesity & Weight Management
  • 9.3 Preventive Metabolic Monitoring
  • 9.4 Sports & Performance Optimization

10 Global Metabolic Health & Continuous Glucose Monitoring Market, By End User

  • 10.1 Hospitals & Clinics
  • 10.2 Homecare Settings
  • 10.3 Fitness & Wellness Centers

11 Global Metabolic Health & Continuous Glucose Monitoring Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Abbott Laboratories
  • 14.2 Dexcom
  • 14.3 Medtronic
  • 14.4 Senseonics Holdings
  • 14.5 Roche Diagnostics
  • 14.6 Ascensia Diabetes Care
  • 14.7 Medtrum Technologies
  • 14.8 i-SENS
  • 14.9 Nemaura Medical
  • 14.10 Bionime Corporation
  • 14.11 Zhejiang POCTech
  • 14.12 Biolinq
  • 14.13 Ultrahuman
  • 14.14 GlySens
  • 14.15 Levels Health
  • 14.16 Nutrisense
  • 14.17 January AI
  • 14.18 Signos

List of Tables

  • Table 1 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Devices (2023-2034) ($MN)
  • Table 4 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Sensors (2023-2034) ($MN)
  • Table 5 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Software & Apps (2023-2034) ($MN)
  • Table 6 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Deployment Mode (2023-2034) ($MN)
  • Table 7 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Wearable Systems (2023-2034) ($MN)
  • Table 8 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Implantable Systems (2023-2034) ($MN)
  • Table 9 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Connectivity & Integration (2023-2034) ($MN)
  • Table 10 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Smartphone-Integrated (2023-2034) ($MN)
  • Table 11 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Cloud-Based Platforms (2023-2034) ($MN)
  • Table 12 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Standalone Devices (2023-2034) ($MN)
  • Table 13 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 14 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 15 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 16 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Online Platforms (2023-2034) ($MN)
  • Table 17 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Application (2023-2034) ($MN)
  • Table 18 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Diabetes Management (2023-2034) ($MN)
  • Table 19 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Obesity & Weight Management (2023-2034) ($MN)
  • Table 20 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Preventive Metabolic Monitoring (2023-2034) ($MN)
  • Table 21 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Sports & Performance Optimization (2023-2034) ($MN)
  • Table 22 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By End User (2023-2034) ($MN)
  • Table 23 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 24 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Homecare Settings (2023-2034) ($MN)
  • Table 25 Global Metabolic Health & Continuous Glucose Monitoring Market Outlook, By Fitness & Wellness Centers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.